The Valley Desk

NCT07104032 · Interventional trial

IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)

Overall registry status Recruiting

Phase 3

Conditions Relapsed/Refractory Primary Central Nervous System Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov